Curemark Garners $18,500,000 New Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    411 Theodore Fremd Ave Rye, NY 10580
  • Company Description
    Curemark is a socially driven biotechnology and development company whose focus is addressing the unmet health needs of individuals in the areas of neurology and gastrointestinal/pancreatic secretory deficiencies.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Curemark will use the funds for the completion and filing requirements for its New Drug Application (NDA) for CM-AT, the company’s autism treatment, and the development of the other therapies in its pipeline.
  • M&A Terms
  • Venture Investor

Trending on Xconomy